全文获取类型
收费全文 | 5165篇 |
免费 | 311篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 150篇 |
妇产科学 | 60篇 |
基础医学 | 661篇 |
口腔科学 | 137篇 |
临床医学 | 640篇 |
内科学 | 1007篇 |
皮肤病学 | 46篇 |
神经病学 | 376篇 |
特种医学 | 408篇 |
外科学 | 845篇 |
综合类 | 88篇 |
一般理论 | 2篇 |
预防医学 | 303篇 |
眼科学 | 86篇 |
药学 | 362篇 |
中国医学 | 16篇 |
肿瘤学 | 262篇 |
出版年
2022年 | 38篇 |
2021年 | 71篇 |
2020年 | 33篇 |
2019年 | 50篇 |
2018年 | 86篇 |
2017年 | 55篇 |
2016年 | 73篇 |
2015年 | 95篇 |
2014年 | 128篇 |
2013年 | 183篇 |
2012年 | 214篇 |
2011年 | 215篇 |
2010年 | 139篇 |
2009年 | 172篇 |
2008年 | 201篇 |
2007年 | 203篇 |
2006年 | 197篇 |
2005年 | 226篇 |
2004年 | 193篇 |
2003年 | 179篇 |
2002年 | 172篇 |
2001年 | 176篇 |
2000年 | 152篇 |
1999年 | 149篇 |
1998年 | 95篇 |
1997年 | 89篇 |
1996年 | 97篇 |
1995年 | 83篇 |
1994年 | 61篇 |
1993年 | 70篇 |
1992年 | 115篇 |
1991年 | 86篇 |
1990年 | 95篇 |
1989年 | 112篇 |
1988年 | 102篇 |
1987年 | 107篇 |
1986年 | 82篇 |
1985年 | 85篇 |
1984年 | 64篇 |
1983年 | 40篇 |
1982年 | 56篇 |
1981年 | 48篇 |
1980年 | 40篇 |
1979年 | 40篇 |
1978年 | 39篇 |
1977年 | 36篇 |
1976年 | 40篇 |
1975年 | 41篇 |
1973年 | 33篇 |
1971年 | 36篇 |
排序方式: 共有5519条查询结果,搜索用时 15 毫秒
11.
12.
13.
The dose/effect relationships for intracameral doses of aceclidine HCl and pilocarpine HCl on total facility of outflow and accommodative amplitude were compared in the cynomolgus monkey eye in vivo. The largest dose of aceclidine tested (20 micrograms), resulted in an average increase of 270% in outflow facility, whereas accommodation was limited to an average of 5 diopters. In contrast, 20 micrograms of intracameral pilocarpine (which is submaximal in increasing facility) resulted in an average of 19 diopters of accommodation. These results provide further evidence for a dissociation between the accommodative and outflow facility functions of the ciliary muscle. 相似文献
14.
Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Heart (British Cardiac Society)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
G. A. Haywood P. R. Rickenbacher P. T. Trindade L. Gullestad J. P. Jiang J. S. Schroeder R. Vagelos P. Oyer M. B. Fowler 《Heart (British Cardiac Society)》1996,75(5):455-462
OBJECTIVE: To analyse the clinical characteristics of patients who died on the Stanford heart transplant waiting list and to develop a method for risk stratifying status 2 patients (outpatients). METHODS: Data were reviewed from all patients over 18 years, excluding retransplants, who were accepted for heart transplantation over an eight year period from 1986 to 1994. RESULTS: 548 patients were accepted for heart transplantation; 53 died on the waiting list, and 52 survived on the waiting list for over one year. On multivariate analysis only peak oxygen consumption (peak VO2: 11.7 (SD 2.7) v 15.1 (5.2) ml/kg/min, P = 0.02) and cardiac output (3.97 (1.03) v 4.79 (1.06) litres/min, P = 0.04) were found to be independent prognostic risk factors. Peak VO2 and cardiac index (CI) were then analysed in the last 141 consecutive patients accepted for cardiac transplantation. All deaths and 88% of the deteriorations to status 1 on the waiting list occurred in patients with either a CI < 2.0 or a VO2 < 12. In those with a CI < 2.0 and a VO2 < 12, 38% died or deteriorated to status 1 in the first year on the waiting list. Patients with CI > or = 2.0 and a VO2 > or = 12 all survived throughout follow up. Using a Cox's proportional hazards model with CI and peak VO2 as covariates, tables were constructed predicting the chance of surviving for (a) 60 days and (b) 1 year on the waiting list. CONCLUSIONS: These data provide a basis for risk stratification of status 2 patients on the heart transplant waiting list. 相似文献
15.
16.
17.
18.
W E Berdel S de Vos J Maurer D Oberberg Z von Marschall J K Schroeder J Li W D Ludwig E D Kreuser E Thiel 《Cancer research》1992,52(12):3498-3502
The growth of a panel of eight different human glioblastoma cell lines was examined in a human tumor cloning assay in agar, a tritiated thymidine uptake assay, and by counting cell numbers, in cultures performed in the absence or presence of increasing concentrations (1 to 100 ng/ml) of recombinant human stem cell factor (SCF). Growth of 7 of 8 cell lines was not significantly and reproducibly affected by recombinant human SCF. However, growth of the CRL 1620 cell line could be stimulated up to 5-fold by the cytokine. In contrast to the other cell lines investigated, CRL 1620 expressed the c-kit protooncogene assessed on the mRNA and protein level. Furthermore, SCF-induced proliferation of CRL 1620 cells was sensitive to the tyrosine kinase inhibitor erbstatin. Our data suggest that SCF can be operative in growth modulation of malignant cells outside the hematopoietic system, and this finding should be further studied for its possible clinical implications. 相似文献
19.